AAV vector delivery to cells in culture

Area of Science:

• Biotechnology
• Molecular Biology
• Gene Therapy

Background:

• Adeno-associated virus (AAV) vectors are crucial tools in gene therapy research.
• Their ability to provide prolonged in vivo gene expression and minimal immune response makes them ideal.
• AAV's episomal maintenance and inability to self-propagate contribute to their safety profile.

Purpose of the Study:

• To explore the potential of AAV gene delivery vectors for treating human diseases.
• To understand the factors influencing AAV vector tropism and cell targeting.
• To highlight the advantages of AAV vectors for sustained gene expression.

Main Methods:

• Review of existing literature on AAV vector development and applications.
• Analysis of AAV serotype diversity and their impact on tissue tropism.
• Investigation of cell-surface receptors mediating AAV entry into target cells.

Main Results:

• AAV vectors are effective for gene therapy across various hereditary and acquired diseases.
• AAV type 2 (AAV2) is a widely used serotype with broad cell delivery capabilities.
• Other AAV serotypes enhance tissue tropism, expanding vector applications.
• Cell-surface receptors like heparin sulfate proteoglycan, alpha2betaV integrin, and FGFR-1 mediate AAV2 entry.

Conclusions:

• AAV vectors are a leading choice for gene therapy due to their safety and efficacy.
• The diverse tropism of AAV vectors, influenced by cell-surface receptors, is key to their broad applicability.
• Further research into AAV serotypes and their interactions can optimize gene therapy strategies.